✦ LIBER ✦

Biochemotherapy with low doses of subcutaneous interleukin-2 in patients with melanoma: results of a phase II trial

✍ Scribed by María González Cao; Susana Puig; Josep Malvehy; Josep Eugeni Herrero; Rosa María Martí; Carlos Conill; Marcelo Sánchez; Begoña Mellado; Pere Gascón; Teresa Castel

Book ID: 110646107
Publisher: Springer Milan
Year: 2005
Tongue: Spanish
Weight: 112 KB
Volume: 7
Category: Article
ISSN: 1699-048X
DOI: 10.1007/bf02710171

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of low-dose total body

A phase II trial of low-dose total body irradiation and subcutaneous Interleukin-2 in metastatic melanoma

✍ Akmal Safwat; Henrik Schmidt; Lars Bastholt; Kirsten Fode; Susanne Larsen; Ninna 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 83 KB

Phase I trial of subcutaneous recombinan

Phase I trial of subcutaneous recombinant human interleukin-2 in patients with metastatic melanoma

✍ Omar Eton; Michael G. Rosenblum; Sewa S. Legha; Wehei Zhang; Mary Jo East; Agop 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 3 views

## Abstract ## BACKGROUND Interleukin‐2 (IL‐2) has activity in metastatic melanoma when given in high doses by the intravenous (IV) route, but its side effects and effectiveness when given in intermediate to high doses by the subcutaneous (SC) route have not been studied adequately. This study sou

Metastatic melanoma patients treated wit

Metastatic melanoma patients treated with dendritic cell vaccination, Interleukin-2 and metronomic cyclophosphamide: results from a phase II trial

✍ Eva Ellebaek, Lotte Engell-Noerregaard, Trine Zeeberg Iversen, Thomas Moerch Fro 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 552 KB

Clinical and immunomodulatory effects of

Clinical and immunomodulatory effects of bevacizumab and low-dose interleukin-2 in patients with metastatic renal cell carcinoma: results from a phase II trial

✍ Jorge A. Garcia; Tarek Mekhail; Paul Elson; Pierre Triozzi; Cheryl Nemec; Robert 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 413 KB

Perioperative immunomodulation with inte

Perioperative immunomodulation with interleukin-2 in patients with renal cell carcinoma: results of a controlled phase II trial

✍ Ornstein, D.K.; Finley, D.S. 📂 Article 📅 2007 🏛 Elsevier Science ⚖ 57 KB

Phase II trial of biochemotherapy with i

Phase II trial of biochemotherapy with interferon α, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trial

✍ Kim A. Margolin; P. Y. Liu; Joseph M. Unger; William S. Fletcher; Lawrence E. Fl 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 79 KB